Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Benz

Showing results (361-370 of 408) with videos related to

Pageof 41
Sort By:
Cancer|November 20, 2009
Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benignMatthias R Benz, Johannes Czernin, Sarah M Dry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2011
(18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinibMatthias R Benz, Ken Herrmann, Franziska Walter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 15, 2011
Metabolic imaging allows early prediction of response to vandetanibMartin A Walter, Matthias R Benz, Isabel J Hildebrandt, et al.
Clinical Nuclear Medicine|May 5, 2023
FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature CellsMasatoshi Hotta, Christine E Mona, Joseph G Crompton, et al.
Cancer|October 25, 2011
3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic responseMatthias R Benz, Johannes Czernin, Martin S Allen-Auerbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2009
18F-FDOPA PET and PET/CT accurately localize pheochromocytomasFarzin Imani, Vatche G Agopian, Martin S Auerbach, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2022
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteriaAndrei Gafita, Isabel Rauscher, Wolfgang P Fendler, et al.
Cancer Chemotherapy and Pharmacology|October 10, 2014
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trialV Gotta, N Widmer, L A Decosterd, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2012
Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PETH Christian Rischke, Matthias R Benz, Damian Wild, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2021
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal AdenocarcinomaMatthias R Benz, Wesley R Armstrong, Francesco Ceci, et al.
Pageof 41

Showing results (361-370 of 408) with videos related to

Sort By:
Pageof 41
Cancer|November 20, 2009
Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benignMatthias R Benz, Johannes Czernin, Sarah M Dry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2011
(18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinibMatthias R Benz, Ken Herrmann, Franziska Walter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 15, 2011
Metabolic imaging allows early prediction of response to vandetanibMartin A Walter, Matthias R Benz, Isabel J Hildebrandt, et al.
Clinical Nuclear Medicine|May 5, 2023
FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature CellsMasatoshi Hotta, Christine E Mona, Joseph G Crompton, et al.
Cancer|October 25, 2011
3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic responseMatthias R Benz, Johannes Czernin, Martin S Allen-Auerbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2009
18F-FDOPA PET and PET/CT accurately localize pheochromocytomasFarzin Imani, Vatche G Agopian, Martin S Auerbach, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2022
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteriaAndrei Gafita, Isabel Rauscher, Wolfgang P Fendler, et al.
Cancer Chemotherapy and Pharmacology|October 10, 2014
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trialV Gotta, N Widmer, L A Decosterd, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2012
Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PETH Christian Rischke, Matthias R Benz, Damian Wild, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2021
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal AdenocarcinomaMatthias R Benz, Wesley R Armstrong, Francesco Ceci, et al.
Pageof 41